Skip to main content
Top
Published in: International Cancer Conference Journal 3/2017

01-07-2017 | Case report

Successful corticosteroid treatment for pleural effusion due to radiation-induced pleuritis after chemoradiotherapy in a patient with esophageal cancer

Authors: Takuro Kumagai, Toru Nakano, Haruo Matsushita, Keiichi Jingu, Noriaki Ohuchi, Takashi Kamei

Published in: International Cancer Conference Journal | Issue 3/2017

Login to get access

Abstract

Concurrent chemoradiotherapy (CRT) is one of the therapies with curative intent used to treat esophageal squamous cell carcinoma (ESCC), and overall survival of patients with esophageal carcinoma treated with CRT has improved. As the number of long-term survivors treated with concurrent CRT has increased, more patients experience late toxicities. A delayed adverse event, such as pleural effusion, is sometimes fatal, but little is known about its treatment. A 72-year-old man diagnosed with ESCC was treated with definitive CRT. He had a complete response to CRT, and 4 years later he complained of dyspnea, caused by pleural effusion. Diuretic agents and drainage of pleural effusion were not sufficiently effective in this case. After oral administration of 30 mg prednisolone, re-accumulation of fluid in the pleural space was controlled and the prednisolone dose was gradually tapered. Corticosteroids could be effective treatment for delayed pleural effusion after radiotherapy, and should be considered an option for treatment-refractory pleural effusion.
Literature
1.
go back to reference Kumekawa Y, Kaneko K, Ito H et al (2006) Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Gastroenterol 41:425–432CrossRefPubMed Kumekawa Y, Kaneko K, Ito H et al (2006) Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Gastroenterol 41:425–432CrossRefPubMed
2.
go back to reference Shigematsu N, Kitamura N, Saikawa Y et al (2007) Death related to pleural and pericardial effusions following chemoradiotherapy in a patient with advanced cancers of the esophagus and stomach. Keio J Med 56(4):124–129CrossRefPubMed Shigematsu N, Kitamura N, Saikawa Y et al (2007) Death related to pleural and pericardial effusions following chemoradiotherapy in a patient with advanced cancers of the esophagus and stomach. Keio J Med 56(4):124–129CrossRefPubMed
3.
go back to reference Kato K, Muro K, Minashi K et al (2011) Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II–III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 81(3):684–690CrossRefPubMed Kato K, Muro K, Minashi K et al (2011) Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II–III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 81(3):684–690CrossRefPubMed
5.
go back to reference Ariga H, Nemoto K, Miyazaki S et al (2009) Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75(2):348–356CrossRefPubMed Ariga H, Nemoto K, Miyazaki S et al (2009) Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75(2):348–356CrossRefPubMed
6.
go back to reference López RM, Cerezo PL (2007) Toxicity associated to radiotherapy treatment in lung cancer patients. Clin Transl Oncol 9:506–512CrossRef López RM, Cerezo PL (2007) Toxicity associated to radiotherapy treatment in lung cancer patients. Clin Transl Oncol 9:506–512CrossRef
7.
go back to reference Yamamoto N, Noda Y, Miyashita Y (2002) A case of refractory bilateral pleural effusion due to post-irradiation constrictive pericarditis. Respirology 7:365–368CrossRefPubMed Yamamoto N, Noda Y, Miyashita Y (2002) A case of refractory bilateral pleural effusion due to post-irradiation constrictive pericarditis. Respirology 7:365–368CrossRefPubMed
8.
go back to reference Friedman DL, Constine LS (2006) Late effects of treatment for Hodgkin lymphoma. J Natl Compr Canc Netw 4:249–257CrossRefPubMed Friedman DL, Constine LS (2006) Late effects of treatment for Hodgkin lymphoma. J Natl Compr Canc Netw 4:249–257CrossRefPubMed
9.
go back to reference Carver JR, Shapiro CL, Ng A et al (2007) American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 25:3991–4008CrossRefPubMed Carver JR, Shapiro CL, Ng A et al (2007) American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 25:3991–4008CrossRefPubMed
10.
go back to reference Morota M, Gomi K, Kozuka T et al (2009) Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 75(1):122–128CrossRefPubMed Morota M, Gomi K, Kozuka T et al (2009) Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 75(1):122–128CrossRefPubMed
11.
go back to reference Shirai K, Tamaki Y, Kitamoto Y et al (2011) Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys 80(4):1002–1007CrossRefPubMed Shirai K, Tamaki Y, Kitamoto Y et al (2011) Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys 80(4):1002–1007CrossRefPubMed
12.
go back to reference Vinaya SK, Jyotsna MJ (2012) Pleural effusion: diagnosis, treatment, and management. Emerg Med 4:31–52 Vinaya SK, Jyotsna MJ (2012) Pleural effusion: diagnosis, treatment, and management. Emerg Med 4:31–52
13.
go back to reference Marks LB, Yorke ED, Jackson A et al (2010) The use of normal tissue complication probability (NTCP) models in the clinic. Int J Radiat Oncol Biol Phys 76:S10–S19CrossRefPubMedPubMedCentral Marks LB, Yorke ED, Jackson A et al (2010) The use of normal tissue complication probability (NTCP) models in the clinic. Int J Radiat Oncol Biol Phys 76:S10–S19CrossRefPubMedPubMedCentral
14.
go back to reference Mehta V (2005) Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 63:5–24CrossRefPubMed Mehta V (2005) Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 63:5–24CrossRefPubMed
15.
go back to reference American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161:646–664CrossRef American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161:646–664CrossRef
16.
go back to reference William CR, David v, Joseph S et al (1982) Myocardial hydroxyproline reduced by early administration of methylprednisolone of ibuprofen to rabbits with radiation-induced heart disease. Circulation 65(5):924–927CrossRef William CR, David v, Joseph S et al (1982) Myocardial hydroxyproline reduced by early administration of methylprednisolone of ibuprofen to rabbits with radiation-induced heart disease. Circulation 65(5):924–927CrossRef
17.
go back to reference Osawa S, Yamada T, Saitoh T et al (2010) Treatment with corticosteroid for pericardial effusion in a patient with advanced synchronous esophageal and gastric cancers following chemoradiotherapy. Case Rep Gastroenterol 4:229–237CrossRefPubMedPubMedCentral Osawa S, Yamada T, Saitoh T et al (2010) Treatment with corticosteroid for pericardial effusion in a patient with advanced synchronous esophageal and gastric cancers following chemoradiotherapy. Case Rep Gastroenterol 4:229–237CrossRefPubMedPubMedCentral
18.
go back to reference Brian S (1978) Corticosteroids in radiation-induced pericarditis. Chest 74(1):96–98CrossRef Brian S (1978) Corticosteroids in radiation-induced pericarditis. Chest 74(1):96–98CrossRef
19.
go back to reference Keelan MH, Rudders RA (1974) Successful treatment of radiation pericarditis with corticosteroids. Arch Intern Med 134:145–147CrossRefPubMed Keelan MH, Rudders RA (1974) Successful treatment of radiation pericarditis with corticosteroids. Arch Intern Med 134:145–147CrossRefPubMed
20.
go back to reference Imazio M, Brucato A, Cumetti D et al (2008) Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 118:667–671CrossRefPubMed Imazio M, Brucato A, Cumetti D et al (2008) Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 118:667–671CrossRefPubMed
Metadata
Title
Successful corticosteroid treatment for pleural effusion due to radiation-induced pleuritis after chemoradiotherapy in a patient with esophageal cancer
Authors
Takuro Kumagai
Toru Nakano
Haruo Matsushita
Keiichi Jingu
Noriaki Ohuchi
Takashi Kamei
Publication date
01-07-2017
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 3/2017
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-017-0293-y

Other articles of this Issue 3/2017

International Cancer Conference Journal 3/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine